Cargando…

Steroid hormones affect binding of the sigma ligand (11)C-SA4503 in tumour cells and tumour-bearing rats

PURPOSE: Sigma receptors are implicated in memory and cognitive functions, drug addiction, depression and schizophrenia. In addition, sigma receptors are strongly overexpressed in many tumours. Although the natural ligands are still unknown, steroid hormones are potential candidates. Here, we examin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rybczynska, Anna A., Elsinga, Philip H., Sijbesma, Jurgen W., Ishiwata, Kiichi, de Jong, Johan R., de Vries, Erik F., Dierckx, Rudi A., van Waarde, Aren
Formato:	Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2009
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2691528/ https://www.ncbi.nlm.nih.gov/pubmed/19247652 http://dx.doi.org/10.1007/s00259-009-1076-2

Ejemplares similares

Sigma-1 Agonist Binding in the Aging Rat Brain: a MicroPET Study with [(11)C]SA4503
por: Ramakrishnan, Nisha K., et al.
Publicado: (2015)

Pridopidine selectively occupies sigma-1 rather than dopamine D2 receptors at behaviorally active doses
por: Sahlholm, Kristoffer, et al.
Publicado: (2015)

Comparison of Sigma 1 Receptor Ligands SA4503 and PRE084 to (+)-Pentazocine in the rd10 Mouse Model of RP
por: Wang, Jing, et al.
Publicado: (2020)

SA4503, A Potent Sigma-1 Receptor Ligand, Ameliorates Synaptic Abnormalities and Cognitive Dysfunction in a Mouse Model of ATR-X Syndrome
por: Yamaguchi, Kouya, et al.
Publicado: (2018)

Allosteric Interactions between Adenosine A(2A) and Dopamine D(2) Receptors in Heteromeric Complexes: Biochemical and Pharmacological Characteristics, and Opportunities for PET Imaging
por: Prasad, Kavya, et al.
Publicado: (2021)

Avenues to molecular imaging of dying cells: Focus on cancer
por: Rybczynska, Anna A., et al.
Publicado: (2018)

The Reversal Effect of Sigma-1 Receptor (S1R) Agonist, SA4503, on Atrial Fibrillation After Depression and Its Underlying Mechanism
por: Liu, Xin, et al.
Publicado: (2019)

Corrigendum: The Reversal Effect of Sigma-1 Receptor (S1R) Agonist, SA4503, on Atrial Fibrillation After Depression and Its Underlying Mechanism
por: Liu, Xin, et al.
Publicado: (2022)

Novel Approach to Repeated Arterial Blood Sampling in Small Animal PET: Application in a Test-Retest Study with the Adenosine A1 Receptor Ligand [(11)C]MPDX
por: Sijbesma, Jürgen W. A., et al.
Publicado: (2016)

Impact of an Adenosine A(2A) Receptor Agonist and Antagonist on Binding of the Dopamine D(2) Receptor Ligand [(11)C]raclopride in the Rodent Striatum
por: Prasad, Kavya, et al.
Publicado: (2022)

Hunting for the high‐affinity state of G‐protein‐coupled receptors with agonist tracers: Theoretical and practical considerations for positron emission tomography imaging
por: Shalgunov, Vladimir, et al.
Publicado: (2018)

Melanoma-associated Chondroitin Sulfate Proteoglycan (MCSP)-targeted delivery of soluble TRAIL potently inhibits melanoma outgrowth in vitro and in vivo
por: de Bruyn, Marco, et al.
Publicado: (2010)

Pharmacokinetic Modeling of [(11)C]GSK-189254, PET Tracer Targeting H(3) Receptors, in Rat Brain
por: Ghazanfari, Nafiseh, et al.
Publicado: (2022)

PET/CT Imaging and Physiology of Mice on High Protein Diet
por: Sijbesma, Jürgen W. A., et al.
Publicado: (2021)

Is cyclooxygenase‐1 involved in neuroinflammation?
por: Ghazanfari, Nafiseh, et al.
Publicado: (2021)

Binding of the Dual-Action Anti-Parkinsonian Drug AG-0029 to Dopamine D(2) and Histamine H(3) Receptors: A PET Study in Healthy Rats
por: Ghazanfari, Nafiseh, et al.
Publicado: (2022)

Test–Retest Repeatability of [(18)F]MC225-PET in Rodents: A Tracer for Imaging of P-gp Function
por: García-Varela, Lara, et al.
Publicado: (2020)

[(18)F]Atorvastatin Pharmacokinetics and Biodistribution in Healthy Female and Male Rats
por: Clemente, Gonçalo S., et al.
Publicado: (2021)

FDG uptake, a surrogate of tumour hypoxia?
por: Dierckx, Rudi Andre, et al.
Publicado: (2008)

Sigma-2 ligands induce tumour cell death by multiple signalling pathways
por: Zeng, C, et al.
Publicado: (2012)

Effect of Dopamine D(2) Receptor Antagonists on [(18)F]-FEOBV Binding
por: Schildt, Anna, et al.
Publicado: (2020)

Total (18)F-dopa PET tumour uptake reflects metabolic endocrine tumour activity in patients with a carcinoid tumour
por: Fiebrich, Helle-Brit, et al.
Publicado: (2011)

Presence and significance of tumour cells in the spleen of tumour-bearing hamsters.
por: Zuinghedau, J., et al.
Publicado: (1979)

STEROID HORMONES AND TUMOURS
Publicado: (1952)

4503 Adaptation of Motor Action in Children with Hemiplegic Cerebral Palsy
por: Dimitropoulou, Katherine, et al.
Publicado: (2020)

The Acute and Early Effects of Whole-Brain Irradiation on Glial Activation, Brain Metabolism, and Behavior: a Positron Emission Tomography Study
por: Parente, Andrea, et al.
Publicado: (2020)

Arginase as a Potential Biomarker of Disease Progression: A Molecular Imaging Perspective
por: S. Clemente, Gonçalo, et al.
Publicado: (2020)

In Vivo Induction of P-Glycoprotein Function can be Measured with [(18)F]MC225 and PET
por: García-Varela, Lara, et al.
Publicado: (2021)

Steroid Therapy in Lymphoid Tumours
por: Groden, B. M., et al.
Publicado: (1963)

Evaluation of [(11)C]CB184 for imaging and quantification of TSPO overexpression in a rat model of herpes encephalitis
por: Vállez Garcia, David, et al.
Publicado: (2015)

The Significance of Splenomegaly in Tumour-Bearing Mice
por: Woodruff, M. F. A., et al.
Publicado: (1962)

Fas Ligand Expression in Lynch Syndrome-Associated Colorectal Tumours
por: Koornstra, Jan J., et al.
Publicado: (2008)

Sigma-2 receptors as a biomarker of proliferation in solid tumours
por: Wheeler, K T, et al.
Publicado: (2000)

PET Imaging with S-[(11)C]Methyl-L-Cysteine and L-[Methyl-(11)C]Methionine in Rat Models of Glioma, Glioma Radiotherapy, and Neuroinflammation
por: Parente, Andrea, et al.
Publicado: (2017)

Potentiation of tumour growth by endotoxin in serum from syngeneic tumour-bearing mice.
por: Kearney, R., et al.
Publicado: (1980)

Repeatability of [(18)F]FDG PET/CT total metabolic active tumour volume and total tumour burden in NSCLC patients
por: Kolinger, Guilherme D., et al.
Publicado: (2019)

Blood Amino Nitrogen in Tumour-bearing Mice
por: Mehairy, M. M. El
Publicado: (1950)

The metabolic response of tumour-bearing mice to fasting.
por: Rofe, A. M., et al.
Publicado: (1985)

Proceedings: Metabolic abnormalities in tumour bearing animals.
por: Calman, K. C., et al.
Publicado: (1975)

Humoral mediation for cachexia in tumour-bearing rats.
por: Tessitore, L., et al.
Publicado: (1993)

Cannot write session to /tmp/vufind_sessions/sess_hjq0uofn4ar2ctqk07mavu8lhe